LIAISON NES®
Simple. Fast. Trusted.
Molecular diagnostic device that is purpose-built for point of care.
When you can make informed, same-visit care decisions, you can help drive better patient outcomes. Unlock fast, reliable answers and differential diagnoses that help to drive more effective patient care while improving antibiotic stewardship.
Product Features
The LIAISON NES® platform represents a breakthrough in molecular diagnostics, bringing laboratory-quality PCR testing to the point of care. Designed for clinical settings where speed and accuracy are critical, LIAISON NES® combines advanced technology with intuitive operation.
With real-time RT-PCR capabilities and a fully automated workflow, healthcare providers can deliver rapid results without compromising quality. The system's compact footprint and connectivity features make it ideal for diverse clinical environments.
From primary care clinics to urgent care centers, LIAISON NES® empowers healthcare professionals to make informed treatment decisions faster, improving patient outcomes and operational efficiency.
Indication for LIAISON NES® FLU A/B, RSV & COVID-19 Assay use
Assay and system
A real-time RT-PCR assay run on the LIAISON NES® to detect influenza A, influenza B, respiratory syncytial virus, and SARS-CoV-2 in one sample.
Patient types
Human patients with signs and symptoms of respiratory tract infection in conjunction with clinical and epidemiological risk factors.
Healthcare settings
Urgent care, physician practices, health systems, and hospitals across outpatient clinics, labs, and emergency departments.
